ConductScience.org, home

Cell line · CVCL_F936

Papers28

PaperJournalYearHow we knowRetractedSource
Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.Acta Pharm Sin B2026Its Methods give the RRID and name the linePubMed
Rose-derived extracellular vesicle-like particles enable anti-melanogenesis by suppressing the key melanogenic pathway in skin cells.Extracell Vesicles Circ Nucl Acids2026Its Methods give the RRID and name the linePubMed
Covalent Inhibition of SHMT2 by Gambogic Acid Induces Ferroptosis Through Mitochondrial Collapse in Triple-Negative Breast Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Spatially programmed Fe and Pt electrode-driven electrochemistry reconditions the tumor microenvironment and sensitizes triple-negative breast cancer to PD-1 Blockade.Front Oncol2026Its Methods give the RRID and name the linePubMed
Autophagy-enhanced hybrid pyroptotic vesicles as personalized vaccines for cancer immunotherapy.J Nanobiotechnology2026Its Methods give the RRID and name the linePubMed
Galangin-loaded biomimetic dendritic cells membrane nanovaccine reprograms the ovarian cancer microenvironment via Stat3/IDO1/AhR axis to boost immunotherapy.Mater Today Bio2026Its Methods give the RRID and name the linePubMed
5G RF-EMFs Mitigate UV-Induced Genotoxic Stress Through Redox Balance and p38 Pathway Regulation in Skin Cells.Antioxidants (Basel)2026Its Methods give the RRID and name the linePubMed
Cancer cachexia-related monocytic myeloid-derived suppressor cells impair T-cell negative selection and predict immune-related adverse events.Liver Res2025Its Methods give the RRID and name the linePubMed
TSH Ligand-Based CAR-T Cell Effectively Eradicates TSHR-Positive Thyroid Cancer with Favorable Safety Profile.Adv Sci (Weinh)2025Its Methods give the RRID and name the linePubMed
The immune response against cancer is modulated by stromal cell fibronectin.Neoplasia2025Its Methods give the RRID and name the linePubMed
Tumor Cell-Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy.Cancer Immunol Res2025Its Methods give the RRID and name the linePubMed
Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy.Cancer Res2025Its Methods give the RRID and name the linePubMed
Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas.Clin Cancer Res2025Its Methods give the RRID and name the linePubMed
Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model.EBioMedicine2025Its Methods give the RRID and name the linePubMed
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.Cancer Res2025Its Methods give the RRID and name the linePubMed
Neddylation signaling inactivation by tetracaine hydrochloride suppresses cell proliferation and alleviates vemurafenib-resistance of melanoma.Cell Biol Toxicol2024Its Methods give the RRID and name the linePubMed
Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerization.Theranostics2024Its Methods give the RRID and name the linePubMed
Exosomes secreted by ST3GAL5high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment.Mol Oncol2024Its Methods give the RRID and name the linePubMed
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade.Cancer Discov2023Its Methods give the RRID and name the linePubMed
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.Neoplasia2023Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_F936/papers